Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Diseases (Basel, Switzerland)|December 24, 2025
Efficacy of Polyvinylpyrrolidone-Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell TransplantationGaetana Porto, Annalisa Pitino, Mercedes Gori, et al.The American Journal of Clinical Nutrition|September 27, 2022
The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) StudyLu Dai, Ziad A Massy, Peter Stenvinkel, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2024
The safety of a low-protein diet in older adults with advanced chronic kidney diseaseKarin Windahl, Nicholas C Chesnaye, Gerd Faxén Irving, et al.Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|May 1, 2021
Patient-Reported Measures and Lifestyle Are Associated With Deterioration in Nutritional Status in CKD Stage 4-5: The EQUAL Cohort StudyKarin Windahl, , Gerd Faxén Irving, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2020
International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality studySamantha Hayward, Barnaby Hole, Rachel Denholm, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 28, 2022
Quality of Life before and after the Start of Dialysis in Older PatientsEsther N M de Rooij, Yvette Meuleman, Johan W de Fijter, et al.Kidney International Reports|October 11, 2022
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD PatientsChava L Ramspek, Rosemarijn Boekee, Marie Evans, et al.Annals of Hematology|April 20, 2023
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantationMassimo Martino, Mercedes Gori, Gaetana Porto, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 4, 2021
Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experienceBarbara Loteta, Annalisa Paviglianiti, Virginia Naso, et al.Cancers|October 16, 2024
First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center StudyMassimo Martino, Mercedes Gori, Gaetana Porto, et al.Pageof 5